UNICA IRIS Institutional Research Information System

FLORIS, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 91.854
NA - Nord America 4.077
AS - Asia 2.325
SA - Sud America 330
AF - Africa 59
OC - Oceania 5
Totale 98.650
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 90.906
US - Stati Uniti d'America 3.994
SG - Singapore 961
CN - Cina 659
VN - Vietnam 251
BR - Brasile 247
SE - Svezia 209
DE - Germania 169
FI - Finlandia 124
FR - Francia 104
UA - Ucraina 95
HK - Hong Kong 83
GB - Regno Unito 80
IN - India 70
CA - Canada 50
JP - Giappone 41
NL - Olanda 40
BD - Bangladesh 37
IQ - Iraq 37
AR - Argentina 31
KR - Corea 30
ES - Italia 29
ZA - Sudafrica 21
MX - Messico 17
PL - Polonia 17
PK - Pakistan 16
ID - Indonesia 15
IR - Iran 14
CO - Colombia 13
RU - Federazione Russa 12
AT - Austria 11
CL - Cile 11
UZ - Uzbekistan 11
EG - Egitto 10
IE - Irlanda 10
MA - Marocco 10
CZ - Repubblica Ceca 9
EC - Ecuador 9
IL - Israele 9
SA - Arabia Saudita 9
TR - Turchia 9
GR - Grecia 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
JO - Giordania 7
PH - Filippine 7
BE - Belgio 6
PS - Palestinian Territory 6
AU - Australia 5
KE - Kenya 5
LT - Lituania 5
TW - Taiwan 5
UY - Uruguay 5
VE - Venezuela 5
AL - Albania 4
PY - Paraguay 4
TN - Tunisia 4
BH - Bahrain 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
PA - Panama 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
JM - Giamaica 2
LV - Lettonia 2
MM - Myanmar 2
OM - Oman 2
PT - Portogallo 2
SR - Suriname 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
ZW - Zimbabwe 1
Totale 98.650
Salva come PNG Salva come JPEG
Città #
Cagliari 88.175
Uta 2.433
Singapore 556
Dallas 540
Ashburn 434
Fairfield 286
San Jose 220
Boardman 191
Woodbridge 177
Houston 169
Chandler 154
Beijing 133
Wilmington 120
Nyköping 116
Ann Arbor 112
Cambridge 107
Los Angeles 107
Seattle 98
Helsinki 93
Shanghai 88
Council Bluffs 81
Hong Kong 73
Santa Clara 71
The Dalles 70
Ho Chi Minh City 66
Lauterbourg 61
Dong Ket 58
Dearborn 52
New York 52
Munich 51
Hefei 50
Boston 45
Jacksonville 42
Buffalo 41
Hanoi 35
Chicago 32
Rome 30
Milan 29
Seoul 29
Tokyo 25
Redwood City 24
São Paulo 23
Nanjing 22
Orem 22
Amsterdam 21
Frankfurt am Main 20
Toronto 20
Baghdad 19
Guangzhou 19
San Diego 19
London 17
Phoenix 17
Montreal 16
Nuremberg 16
Warsaw 15
Brooklyn 12
Da Nang 12
Lappeenranta 12
Redondo Beach 12
Denver 11
Madrid 11
Mumbai 11
Nanchang 11
Tashkent 11
Chennai 10
Haiphong 10
Johannesburg 10
Salt Lake City 10
Turku 10
Dhaka 9
Elk Grove Village 9
Hebei 9
Shenzhen 9
Belo Horizonte 8
Changsha 8
Mountain View 8
Paris 8
Stockholm 8
Buenos Aires 7
Dublin 7
Düsseldorf 7
Hyderabad 7
Rio de Janeiro 7
Santiago 7
Tianjin 7
Xi'an 7
Baku 6
Brussels 6
Erbil 6
Falls Church 6
Guayaquil 6
Poplar 6
Portsmouth 6
San Mateo 6
Tampa 6
Vancouver 6
Vienna 6
Washington 6
Amman 5
Atlanta 5
Totale 95.959
Salva come PNG Salva come JPEG
Nome #
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 10.743
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 3.171
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 3.060
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 3.054
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 3.019
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.903
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.820
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.820
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.791
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus 2.626
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 2.611
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.332
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 2.285
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 2.253
Polymyalgia rheumatica: an autoinflammatory disorder? 2.241
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 2.180
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 2.179
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.164
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 2.092
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 2.072
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 2.025
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.939
The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice 1.798
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.698
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 1.644
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.626
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.571
Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study 1.480
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties 1.361
The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist 1.273
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort 1.174
Targeted Therapies in Axial Psoriatic Arthritis 1.170
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 1.144
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study 1.075
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 1.070
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study 1.060
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.043
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study 1.037
Imbalanced MMP-3 and MMP-12 serum levels in systemic lupus erythematosus patients with Jaccoud's arthropathy and a distinctive MRI pattern 989
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 927
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 906
Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis 891
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis 875
Organ damage is a major determinant of work productivity impairment in Behçet's Syndrome: a post-hoc analysis of the BODI validation study 867
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 853
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 846
Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study 838
Discordance between patient and physician global assessment of disease activity in Behçet’s syndrome: a multicenter study cohort 815
Musculoskeletal ultrasound may narrow the gap between patients and physicians in the assessment of rheumatoid arthritis disease activity 796
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 766
Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study 761
SAT0035 IS PHARMACOLOGICAL CLINICAL REMISSION SYNONYMOUS WITH BIOLOGICAL INACTIVE DISEASE? DIFFERENTIAL GENE EXPRESSION ANALYSIS IN RHEUMATOID ARTHRITISAND HEALTY CONTROLS 711
Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study 561
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 532
Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes 340
Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature Review 237
Mood Disorder Questionnaire Positivity in Systemic Lupus Erythematosus and Other Chronic Diseases including Screen Bipolar Disorders or Rhythm and Energy Dysregulation Syndromes (DYMERS) 232
Stratifying patients by TNFSF13B genotype revealed increased flare and renal flare risk, but a greater benefit from belimumab: a potential biomarker for personalized treatment in systemic lupus erythematosus 169
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 84
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 83
The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis 79
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 63
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 59
The metabolomic profile of psoriatic arthritis patients unveils the unbalance of disease-related molecules and pathways 49
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry 35
Ultrasound-Guided Synovial Biopsy Can Be Effectively and Safely Performed in Different Clinical Settings Favouring a Widespread Application of Precision Medicine in Rheumatoid Arthritis: A Post-hoc Analysis of Three Clinical Trials 32
null 5
Totale 99.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.173 0 0 0 0 0 0 0 0 0 828 836 509
2021/20225.007 425 243 264 187 355 302 254 297 520 600 908 652
2022/20236.923 568 895 696 503 508 763 403 565 515 548 621 338
2023/202413.146 362 372 389 777 1.052 1.409 1.457 4.113 495 567 1.210 943
2024/202531.521 11.169 8.598 5.106 2.186 1.164 1.147 1.259 86 199 163 221 223
2025/20264.949 335 403 623 347 478 362 1.009 512 420 460 0 0
Totale 99.005